The state of oncological care in Russia: malignant skin neoplasms (C44). Part 1. Prevalence, quality of accounting, age characteristics, localization, and histological structure (clinical-population study)

Abstract

This work represents a clinical-population study of the state of oncological care in Russia, focused on malignant skin neoplasms (C44). The study analyzes data on the prevalence of this disease, the quality of case accounting, age characteristics, and the localization and histological structure of tumors. The aim of this research is to continue the investigation into the patterns of prevalence of skin neoplasms (C44), assess the quality of primary accounting, and evaluate the impact of the coronavirus infection epidemic on analytical indicators of prevalence and patient survival. The conducted study confirmed the trend of increasing morbidity and decreasing mortality from skin neoplasms (C44) among the population of Russia and the Northwestern Federal District of the Russian Federation. A clear positive dynamics in the quality of accounting is observed. Special attention is given to the specifics of morbidity changes in neoplasms (C44) considering each age group of the population of Russia. At the population level, the age-specific mortality of patients is presented for each year of observation, analyzed in the context of five-year cohort groups. For the first time, a trend has been identified showing an increase in annual mortality from skin neoplasms (C44) after the sixth year of observation following the treatment of patients.

Keywords

malignant cutaneous melanoma / morbidity / mortality / quality of accounting / impact of the coronavirus infection pandemic / detailed localization and histological structure / treatment efficacy

References

[1] Cancer Incidence in Five Continents. Volume XII. Registry Summary tables. https://ci5.iarc.fr/ci5-xii/tables/summary

[2] Cancer Incidence in Five Continents. Volume VI. IARC Scientific Publication No. 120. Edited by Parkin D. M., Muir C. S., Whelan S. L., Gao Y-T, Ferlay J, Powell J. Lyon, 1992

[3] Cancer Incidence in Five Continents. Volume VII. IARC Scientific Publication No. 143. Edited by Parkin D. M., Whelan S. L., Ferlay J, Raymond L, Young J. Lyon, 1997

[4] Cancer Incidence in Five Continents. Volume VIII. IARC Scientific Publication No. 155. Edited by Parkin D. M., Whelan S. L., Ferlay J, Teppo L, Thomas D. B. Lyon, 2002

[5] Cancer Incidence in Five Continents. Volume IX. IARC Scientific Publication No. 160. Edited by Curado M. P., Edwards B, Shin H. R., Storm H, Ferlay J, Heanue M, Boyle P. Lyon, 2007

[6] Cancer Incidence in Five Continents. Volume X. IARC Scientific Publication No. 164. Edited by Forman D., Bray F., Brewster D. H., Gombe Mbalawa C., Kohler B., Piñeros M., Steliarova-Foucher E, Swaminathan R, Ferlay J. Lyon, 2014

[7] Cancer Incidence in Five Continents. Volume X. IARC Scientific Publication No. 164. Edited by Forman D., Bray F., Brewster D. H., Gombe Mbalawa C., Kohler B., Piñeros M., Steliarova-Foucher E, Swaminathan R, Ferlay J. Lyon, 2014.

[8] Malignant tumors in Russia in 2015 (morbidity and mortality) / Ed. A. D. Kaprin, V. V. Starinskogo, G. V. Petrovoi. – M.: P. A. Herzen MSIOI – filial of NMRC of radiology Ministry of Public Health of the Russian Federation, 2016. – p. 250. (In Russ).

[9] Злокачественные новообразования в России в 2015 году (заболеваемость и смертность) /Под ред. А. Д. Каприна, В. В. Спринского, Г. В. Петровой. – М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2017. – 250с.

[10] Malignant tumors in Russia in 2022 (morbidity and mortality) / Ed. A. D. Kaprina, V. V. Starinskogo, A. O. Shakhzadova, I. V. Lisichnikovoi. – M.: P. A. Herzen MSIOI – filial of NMRC of radiology Ministry of Public Health of the Russian Federation, 2023. – 275 p. (In Russ).

[11] Злокачественные новообразования в России в 2022 году (заболеваемость и смертность) / Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой, И. В. Лисичниковой. – М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2023. ИЛЛ – 275 с.

[12] Merabishvili V. M. Coronaviruses and cancer in Russia / V. M. Merabishvili // Issues of oncology. – 2022. – Vol. 68, No. 4. – P. 381–392. – doi: 10.37469/0507-3758-2022-68-4-381-392. (In Russ).

[13] Мерабишвили В. М. Коронавирусы и рак в России / В. М. Мерабишвили // Вопросы онкологии. – 2022. – Т. 68, № 4. – С. 381–392. – doi: 10.37469/0507-3758-2022-68-4-381-392.

[14] Malignant tumors in Russia in 2010 (morbidity and mortality) / Ed. V. I. Chissova, V. V. Starinskogo, G. V. Petrovoi. – M.: P. A. Herzen MSIOI, 2012. – p. 260. (In Russ).

[15] Злокачественные новообразования в России в 2010 году (заболеваемость и смертность) / Под ред. В. И. Чиссова, В. В. Старинского, Г. В. Петровой – М.: МНИОИ им. П. А. Герцена, 2012. – 260 с.

[16] Malignant tumors in Russia in 2019 (morbidity and mortality) / Ed. A. D. Kaprina, V. V. Starinskogo, G. V. Petrovoi. – M.: P. A. Herzen MSIOI – filial of NMRC of radiology Ministry of Public Health of the Russian Federation, 2020. – p. 214. (In Russ).

[17] Злокачественные новообразования в России в 2019 году (заболеваемость и смертность) / Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой. – М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2020. – 214 c.

[18] Malignant tumors in Russia in 2020 (morbidity and mortality) / Ed. A. D. Kaprina, V. V. Starinskogo, A. O. Shahzadovoi. – M.: P. A. Herzen MSIOI – filial of NMRC of radiology Ministry of Public Health of the Russian Federation, 2021. – p. 252. (In Russ).

[19] Злокачественные новообразования в России в 2020 году (заболеваемость и смертность) / Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой. – М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2021. – 252 с.

[20] Malignant tumors in Russia in 2020 (morbidity and mortality) / Ed. A. D. Kaprina, V. V. Starinskogo, A. O. Shahzadovoi. – M.: P. A. Herzen MSIOI – filial of NMRC of radiology Ministry of Public Health of the Russian Federation, 2022. – p. 252. (In Russ).

[21] Злокачественные новообразования в России в 2021 году (заболеваемость и смертность) / Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой. – М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. – 252 с.

[22] Malignant tumors in Russia in 2000 (morbidity and mortality) / Ed. V. I. Chissova, V. V. Starinskogo. – M.: P. A. Herzen MSIOI, 2002. – p. 264. (In Russ).

[23] Злокачественные новообразования в России в 2000 году (заболеваемость и смертность)/Под ред. В. И. Чиссова, В. В. Старинского. – М.: МНИОИ им. П. А. Герцена, 2002. – 264 с.

[24] Merabishvili V. M. Analytical index of accuracy // Questions of oncology. – 2018. – Vol. 64. – No. 3. – P. 445–452. (In Russ).

[25] Мерабишвили В. М. Аналитические показатели. Индекс достоверности учета// Вопросы онкологии. – 2018. – 64(3). – P:445–452.

[26] Merabishvili V. M. Index of accuracy – the main criteria for an objective assessment of the activity of the oncological service for all localities of malignant tumors, regardless of the level of lethality of patients // Questions of Oncology. – 2019. – Vol. 65. – No. 4. – p.510–515. (In Russ).

[27] Мерабишвили В. М. Индекс достоверности учета – важнейший критерий объективной оценки деятельности онкологической службы для всех локализаций ЗНО, независимо от уровня летальности больных // Вопросы онкологии. – 2019. – Т. 65, № 4. С. 510–515

[28] Merabishvili V. M. Oncology statistic. Part I. Second edition, expanded – Saarbrüchen, Dentschland (Germany): Lap Lambert Academic Publishing, 2015. – 223 p. (In Russ).

[29] Мерабишвили В. М. Онкологическая статистика. Часть I. Второе издание, дополненное. – Saarbrücken, Deutschland (Германия): Lap Lambert Academic Publishing, 2015. – 221 с.

[30] Merabishvili V. M. Oncology statistic. Part II. Second edition, expanded – Saarbrüchen, Dentschland (Germany): Lap Lambert Academic Publishing, 2015. – 248 p. (In Russ).

[31] Мерабишвили В. М. Онкологическая статистика. Часть II. Второе издание, дополненное. – Saarbrücken, Deutschland (Германия): Lap Lambert Academic Publishing, 2015. – 247 c.

[32] Garanina O. E. Non-invasive methods for diagnosing skin tumors and their potential for screening for skin melanoma: a systematic literature review / O. E. Garanina, I. V. Samoylenko, I. L. Shlivko [et al.] // Medical Council. – 2020. – No. 9. – P. 102–120. – doi: 10.21518/2079-701X-2020-9-102-120.

[33] Гаранина, О. Е. Неинвазивные методы диагностики опухолей кожи и их потенциал применения для скрининга меланомы кожи: систематический обзор литературы / О. Е. Гаранина, И. В. Самойленко, И. Л. Шливко [и др.] // Медицинский совет. – 2020. – № 9. – С. 102–120. – doi: 10.21518/2079-701X-2020-9-102-120

[34] Ligeralde-Bascones K. I., Gulmatico-Flores Z., Lim-Bueser H. G., Espinoza-Thaebtharm A., Rescober-Valencia M. C., Aguila K. P., Anupol E. B.J., Balete S. L., Barcelona M. V., Castro V. C.S., Fineza-Dela Cruz A. M.B., Lansangan P. P., Manrique A. M. B., Olitoquit K. D., Ortiz A. C.G., Palisoc E. D., Santos D. G.V., See M. R.V., Sy A. J.F., Sy G. C., Tana M. G., Tayag J. J.S., Teo H. M. T. Diagnosis and management of basal cell carcinoma: interdisciplinary consensus statements of Jose R. Reyes Memorial Medical Center, a Department of Health Tertiary Hospital in Manila, Philippines // Int J Dermatol. – 2023. – Vol. 62, No. 6. – P. 812–821.

[35] Ligeralde-Bascones K. I., Gulmatico-Flores Z., Lim-Bueser H. G., Espinoza-Thaebtharm A., Rescober-Valencia M. C., Aguila K. P., Anupol E. B.J., Balete S. L., Barcelona M. V., Castro V. C. S., Fineza-Dela Cruz A. M.B., Lansangan P. P., Manrique A. M.B., Olitoquit K. D., Ortiz A. C. G., Palisoc E. D., Santos D. G. V., See M. R.V., Sy A. J.F., Sy G. C., Tana M. G., Tayag J. J.S., Teo H. M.T. Diagnosis and management of basal cell carcinoma: interdisciplinary consensus statements of Jose R. Reyes Memorial Medical Center, a Department of Health Tertiary Hospital in Manila, Philippines // Int J Dermatol. – 2023. – Vol. 62, No. 6. – P. 812–821.

[36] Naik P. P., Desai M. B. Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management // Oncol Ther. – 2022. – Vol. 10, No. 2. – P. 317–335.

[37] Tanese K. Diagnosis and Management of Basal Cell Carcinoma // Curr Treat Options Oncol. – 2019. – Vol. 20, No. 2. – P. 13.

[38] Lallas A., Apalla Z., Ioannides D., Argenziano G., Castagnetti F., Moscarella E., Longo C., Palmieri T., Ramundo D., Zalaudek I. Dermoscopy in the diagnosis and management of basal cell carcinoma // Future Oncol. – 2015. – Vol. 11, No. 22. – P. 2975–84.

[39] Cheng H. M., Guitera P. Systematic review of optical coherence tomography usage in the diagnosis and management of basal cell carcinoma // Br J Dermatol. – 2015. – Vol. 173, No. 6. – P. 1371–80.

[40] Fabiano A., Argenziano G., Longo C., Moscarella E., Specchio F., Lallas A. Dermoscopy as an adjuvant tool for the diagnosis and management of basal cell carcinoma // G Ital Dermatol Venereol. – 2016. – Vol. 151, No. 5. – P. 530–4.

[41] Reiter O., Mimouni I., Gdalevich M., Marghoob A. A., Levi A., Hodak E., Leshem Y. A. The diagnostic accuracy of dermoscopy for basal cell carcinoma: A systematic review and meta-analysis // J Am Acad Dermatol. – 2019. – Vol. 80, No. 5. – P. 1380–1388.

[42] Klein C. M., Sivesind T. E., Dellavalle R. P. From the Cochrane Library: Visual Inspection and Dermoscopy, Alone or in Combination, for Diagnosing Keratinocyte Skin Cancers in Adults // JMIR Dermatol. – 2024. – Vol. 7. – P. e41657.

[43] Dinnes J., Deeks J. J., Chuchu N., Matin R. N., Wong K. Y., Aldridge R. B., Durack A., Gulati A., Chan S. A., Johnston L., Bayliss S. E., Leonardi-Bee J., Takwoingi Y., Davenport C., O’Sullivan C., Tehrani H., Williams H. C., Cochrane Skin Cancer Diagnostic Test Accuracy G. Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults // Cochrane Database Syst Rev. – 2018. – Vol. 12, No. 12. – P. CD011901.

[44] Dinnes J., Deeks J. J., Chuchu N., Matin R. N., Wong K. Y., Aldridge R. B., Durack A., Gulati A., Chan S. A., Johnston L., Bayliss S. E., Leonardi-Bee J., Takwoingi Y., Davenport C., O’Sullivan C., Tehrani H., Williams H. C. Cochrane Skin Cancer Diagnostic Test Accuracy G. Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults // Cochrane Database Syst Rev. – 2018. – Vol. 12, No. 12. – P. CD011901.

[45] Lallas A., Tzellos T., Kyrgidis A., Apalla Z., Zalaudek I., Karatolias A., Ferrara G., Piana S., Longo C., Moscarella E., Stratigos A., Argenziano G. Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma // J Am Acad Dermatol. – 2014. – Vol. 70, No. 2. – P. 303–11.

[46] Lallas A., Pyne J., Kyrgidis A., Andreani S., Argenziano G., Cavaller A., Giacomel J., Longo C., Malvestiti A., Moscarella E., Piana S., Specchio F., Hofmann-Wellenhof R., Zalaudek I. The clinical and dermoscopic features of invasive cutaneous squamous cell carcinoma depend on the histopathological grade of differentiation // Br J Dermatol. – 2015. – Vol. 172, No. 5. – P. 1308–15.

[47] Hernandez C., del Boz J., de Troya M. Can high-frequency skin ultrasound be used for the diagnosis and management of Basal cell carcinoma? // Actas Dermosifiliogr. – 2014. – Vol. 105, No. 2. – P. 107–11.

[48] Ferrante di Ruffano L., Dinnes J., Chuchu N., Bayliss S. E., Takwoingi Y., Davenport C., Matin R. N., O’Sullivan C., Roskell D., Deeks J. J., Williams H. C., Cochrane Skin Cancer Diagnostic Test Accuracy G. Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults // Cochrane Database Syst Rev. – 2018. – Vol. 12, No. 12. – P. CD013187.

RIGHTS & PERMISSIONS

Eco-Vector